Financials
- Market Capitalization 49.48 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.33
ratio cours/chiffre d'affaires
664.32
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4280 | TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.09 USD | +0.48% | +2.45% | -6.28% | -21.70% | 51.04 M USD | ||
| 4296 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.32 USD | 0.00% | +0.76% | +14.78% | -8.33% | 49.69 M USD | ||
| 4312 | ATYR aTyr Pharma, Inc. - Common Stock | 0.49 USD | -2.00% | -16.95% | +11.36% | -49.48% | 48.05 M USD | ||
| 4343 | HYPD Hyperion DeFi, Inc. - Common Stock | 2.96 USD | -0.34% | +4.59% | -0.34% | -77.23% | 44.87 M USD |